GR3003244T3 - Use of oligopeptids for the treatment of cerebral disorders - Google Patents

Use of oligopeptids for the treatment of cerebral disorders

Info

Publication number
GR3003244T3
GR3003244T3 GR91401870T GR910401870T GR3003244T3 GR 3003244 T3 GR3003244 T3 GR 3003244T3 GR 91401870 T GR91401870 T GR 91401870T GR 910401870 T GR910401870 T GR 910401870T GR 3003244 T3 GR3003244 T3 GR 3003244T3
Authority
GR
Greece
Prior art keywords
treatment
oligopeptids
cerebral disorders
tryptophan
cerebral
Prior art date
Application number
GR91401870T
Other languages
English (en)
Inventor
Klaus Sommermeyer
Burghard Weidler
Original Assignee
Fresenius Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Ag filed Critical Fresenius Ag
Publication of GR3003244T3 publication Critical patent/GR3003244T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GR91401870T 1986-01-18 1991-12-02 Use of oligopeptids for the treatment of cerebral disorders GR3003244T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601398 DE3601398A1 (de) 1986-01-18 1986-01-18 Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen

Publications (1)

Publication Number Publication Date
GR3003244T3 true GR3003244T3 (en) 1993-02-17

Family

ID=6292132

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401870T GR3003244T3 (en) 1986-01-18 1991-12-02 Use of oligopeptids for the treatment of cerebral disorders

Country Status (7)

Country Link
US (1) US4849408A (el)
EP (1) EP0234186B1 (el)
JP (1) JPS62169730A (el)
AT (1) ATE69163T1 (el)
DE (2) DE3601398A1 (el)
ES (1) ES2038603T3 (el)
GR (1) GR3003244T3 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823464A1 (de) * 1988-07-11 1990-01-18 Asta Pharma Ag Neue tryptophandipeptide
US5759991A (en) * 1990-03-29 1998-06-02 Sumitomo Pharmaceutical Company, Limited. Neurotrophic peptide derivatives
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
JP4698843B2 (ja) * 1999-05-17 2011-06-08 エーザイ インコーポレイテッド 生体活性剤の改良された細胞取り込み
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
ES2375958T3 (es) * 2002-12-03 2012-03-07 Pathogen Removal And Diagnostic Technologies, Inc. Ligandos de prote�?nas priones y procedimientos de uso.
RU2663691C2 (ru) * 2013-12-13 2018-08-08 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Фармацевтическая композиция амида n-(6-фенилгексаноил)глицил-l-триптофана с пленочным покрытием и способы ее получения
WO2018200381A1 (en) * 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
JPS51115909A (en) * 1975-04-01 1976-10-13 Otsuka Pharmaceut Factory Inc A process for preparing amino acid parenteral injection mixed with a r educing sugar
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
GB8319174D0 (en) * 1983-07-15 1983-08-17 Erba Farmitalia Biologically active heptapeptides
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
ES2061442T3 (es) * 1985-10-14 1994-12-16 Nippon Zoki Pharmaceutical Co Peptidos.

Also Published As

Publication number Publication date
DE3601398A1 (de) 1987-07-23
JPS62169730A (ja) 1987-07-25
ES2038603T3 (es) 1993-08-01
US4849408A (en) 1989-07-18
EP0234186A1 (de) 1987-09-02
ATE69163T1 (de) 1991-11-15
DE3774291D1 (de) 1991-12-12
EP0234186B1 (de) 1991-11-06

Similar Documents

Publication Publication Date Title
EP0441119A3 (en) The use of l-arginine in the treatment of hypertension and other vascular disorders
CS553490A3 (en) Transdermal therapeutic system
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
MY131298A (en) 5-heteroyl indole derivatives
EP0465158A3 (en) Apparatus for use in the treatment of spinal disorders
GR3006630T3 (el)
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
EP0326023A3 (en) Benzamide against cognitive disorders
GR3003244T3 (en) Use of oligopeptids for the treatment of cerebral disorders
NZ504419A (en) The use of carvedilol for treating amyloid diseases such as Alzheimer's
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
AU1029588A (en) Synergistic combination of azelastine and theophylline or azelastine and beta-mimetics
ZA871062B (en) Use of aromatic diamines for the treatment of angina and diamines therefor
EP0329961A3 (en) Use of 2-oxo-pyrrolidine-1-acetamide for the determination of glomerular filtration rate in humans
CA2068630A1 (en) Use of protein c or activated protein c
TW282455B (el)
EP0450757A3 (en) Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
DK0519902T3 (el)
ZA929390B (en) The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE68911509D1 (de) 26-aminocholesterol und derivate und analoge davon bei der regulierung der cholesterolanhäufung in den körpergefässen.
GR3019819T3 (en) Use of wild garlic for the therapy or prevention of blood circulation disturbances.
IL89901A0 (en) Strobilurine derivatives